Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001447028-21-000059
Filing Date
2021-11-04
Accepted
2021-11-04 16:07:33
Documents
59
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q abus-20210930.htm   iXBRL 10-Q 1378064
2 EX-31.1 a2021-q310xqex311.htm EX-31.1 10914
3 EX-31.2 a2021-q310xqex312.htm EX-31.2 10932
4 EX-32.1 a2021-q310xqex321.htm EX-32.1 4939
5 EX-32.2 a2021-q310xqex322.htm EX-32.2 4969
11 PIPELINE abus-20210930_g1.jpg GRAPHIC 66055
  Complete submission text file 0001447028-21-000059.txt   5618652

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20210930.xsd EX-101.SCH 37339
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abus-20210930_cal.xml EX-101.CAL 55488
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20210930_def.xml EX-101.DEF 157083
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20210930_lab.xml EX-101.LAB 435926
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20210930_pre.xml EX-101.PRE 271577
12 EXTRACTED XBRL INSTANCE DOCUMENT abus-20210930_htm.xml XML 922804
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 211379944
SIC: 2834 Pharmaceutical Preparations